First Parkinson's Patient Receives iPS Cell Treatment at Kyoto University Hospital
Japanese pharmaceutical company Sumitomo Pharma announced on October 30 that the first patient to receive its newly approved regenerative medicine treatment for Parkinson's disease underwent a successful brain cell transplant at Kyoto University Hospital in early October, with the woman in her 50s already returning to work and recovering well. (News On Japan)
We haven't written up this one. News On Japan has the full story — the link below goes straight to it.
